A few considerations to think about when wanting to maximise profit for your lateral flow rapid test.
What barriers can be broken down to aid recruitment and retention of clinical trial volunteers?
Octylphenol ethoxylates are now included in the Annex XIV of REACH. What does it mean for LFIAs that use OPEs?
See how rapid near-patient tests and data solutions can facilitate a patient centric approach to clinical trials.
Switching lateral flow manufacturer doesn’t have to be a headache and could change the prospects of your business.
Patient-experience and clinician-needs should be at the heart of monitoring drug therapy. Is there a device that aid these patient and clinician needs?
The use of near-patient test and mHealth technology for aiding therapeutic differentiation.
We look at where NALFIA tests can have a positive impact on budgets and workloads.
Learn which pocket-dwelling item is a potential solution for some of primary care challenges
Who is benefiting from the use of lateral flow Smartphone readers and why is affordability driving the use of this testing solution?
In this Meet the Team post, we hear from Meena Shemar (Assay Development Manager).